NCT00538525
Completed
Not Applicable
Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer
ConditionsBreast Cancer
InterventionsDoxorubicin, Docetaxel, Cisplatin
Overview
- Phase
- Not Applicable
- Intervention
- Doxorubicin, Docetaxel, Cisplatin
- Conditions
- Breast Cancer
- Sponsor
- King Faisal Specialist Hospital & Research Center
- Enrollment
- 10
- Primary Endpoint
- Effectiveness
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with locally advanced breast cancer
Exclusion Criteria
- •Patients with metastatic breast cancer
Arms & Interventions
Arm 1
Doxorubicin, Docetaxel, Cisplatin
Intervention: Doxorubicin, Docetaxel, Cisplatin
Outcomes
Primary Outcomes
Effectiveness
Time Frame: overall
Similar Trials
Completed
Phase 2
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast CancerBreast CancerMetastatic Breast CancerNCT00404066George Albert Fisher21
Completed
Phase 2
Phase II Study of Docetaxel Plus CDDP for NSCLC Stage IIINSCLCNCT00172380National Taiwan University Hospital41
Unknown
Phase 2
Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by SurgeryBreast CancerNCT00801411National Cancer Centre, Singapore318
Terminated
Phase 2
Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryLung CancerNCT00293332University of California, San Francisco1
Unknown
Phase 2
A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell CarcinomaStage II and III Esophageal Squamous Cell CarcinomaNCT02915965Sun Yat-sen University80